Outset Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Janeiro 2024 - 10:30AM
Business Wire
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical
technology company pioneering a first-of-its-kind technology to
reduce the cost and complexity of dialysis, today announced that
members of management will present at the 42nd annual J.P. Morgan
Healthcare conference on Monday, January 8, 2024, at 5:15 p.m.
Pacific time.
A live and archived webcast of the presentation will be
available on the “Investors” section of the Outset website at
https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a
first-of-its-kind technology to reduce the cost and complexity of
dialysis. The Tablo® Hemodialysis System, FDA cleared for use from
the hospital to the home, represents a significant technological
advancement that transforms the dialysis experience for patients
and operationally simplifies it for providers. Tablo serves as a
single enterprise solution that can be utilized across the
continuum of care, allowing dialysis to be delivered anytime,
anywhere and by anyone. The integration of water purification and
on-demand dialysate production enables Tablo to serve as a dialysis
clinic on wheels, with 2-way wireless data transmission and a
proprietary data analytics platform powering a new holistic
approach to dialysis care. Tablo is a registered trademark of
Outset Medical, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240103380883/en/
Jim Mazzola Vice President, Investor Relations
jmazzola@outsetmedical.com
Outset Medical (NASDAQ:OM)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Outset Medical (NASDAQ:OM)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024